Secukinumab
( DrugBank: Secukinumab / KEGG DRUG: Secukinumab )
8 diseases
告示番号 | 疾患名(ページ内リンク) | 臨床試験数 |
---|---|---|
13 | 多発性硬化症/視神経脊髄炎 | 12 |
37 | 膿疱性乾癬(汎発型) | 14 |
41 | 巨細胞性動脈炎 | 17 |
46 | 悪性関節リウマチ | 44 |
告示番号 | 疾患名(ページ内リンク) | 臨床試験数 |
---|---|---|
107 | 若年性特発性関節炎 | 13 |
160 | 先天性魚鱗癬 | 2 |
269 | 化膿性無菌性関節炎・壊疽性膿皮症・アクネ症候群 | 3 |
271 | 強直性脊椎炎 | 85 |
13. 多発性硬化症/視神経脊髄炎
臨床試験数 : 3,685 / 薬物数 : 1,932 - (DrugBank : 355) / 標的遺伝子数 : 263 - 標的パスウェイ数 : 237
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|
37. 膿疱性乾癬(汎発型)
臨床試験数 : 93 / 薬物数 : 50 - (DrugBank : 21) / 標的遺伝子数 : 21 - 標的パスウェイ数 : 99
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|
41. 巨細胞性動脈炎
臨床試験数 : 154 / 薬物数 : 139 - (DrugBank : 37) / 標的遺伝子数 : 33 - 標的パスウェイ数 : 125
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|
46. 悪性関節リウマチ
臨床試験数 : 4,543 / 薬物数 : 2,251 - (DrugBank : 390) / 標的遺伝子数 : 198 - 標的パスウェイ数 : 232
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|
107. 若年性特発性関節炎
臨床試験数 : 477 / 薬物数 : 232 - (DrugBank : 53) / 標的遺伝子数 : 66 - 標的パスウェイ数 : 160
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|
160. 先天性魚鱗癬
臨床試験数 : 57 / 薬物数 : 68 - (DrugBank : 25) / 標的遺伝子数 : 21 - 標的パスウェイ数 : 141
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|
269. 化膿性無菌性関節炎・壊疽性膿皮症・アクネ症候群
臨床試験数 : 32 / 薬物数 : 32 - (DrugBank : 16) / 標的遺伝子数 : 17 - 標的パスウェイ数 : 106
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|
271. 強直性脊椎炎
臨床試験数 : 603 / 薬物数 : 302 - (DrugBank : 69) / 標的遺伝子数 : 40 - 標的パスウェイ数 : 146
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|